• Publications
  • Influence
Safety of Adjuvant Endocrine Therapy in Postmenopausal Women With Breast Cancer
The use of aromatase inhibitors (AIs) as adjuvant endocrine therapy for hormone-sensitive breast cancer is increasing, as these drugs are more effective than tamoxifen alone in improving disease-freeExpand
  • 15
  • 2
Activity of azacitidine in chronic myelomonocytic leukemia
Hypomethylating drugs are useful in the management of myelodysplastic syndrome (MDS). Two of these drugs, azacitidine and decitabine, have received FDA approval for the treatment of MDS and chronicExpand
  • 80
  • 1
The role of azacitidine in the treatment of myelodysplastic syndromes
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic disorders characterized by ineffective hematopoiesis and potential transformation to acute myeloid leukemia. Supportive careExpand
  • 19
Recent advances in myelodysplastic syndromes.
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal bone marrow disorders characterized by both bone marrow failure and a propensity for development of acute myeloid leukemia. TheExpand
  • 20
Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
Long-term disease-free survival in adults with T-cell acute lymphoblastic leukemia (T-ALL) remains poor, particularly after relapse, with few available salvage options. Preclinical data suggest thatExpand
  • 9
  • Open Access
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-Immune Hemolytic Anemia
Rosai-Dorfman disease (RDD) is a rare benign histiocytic proliferative disorder predominantly of the lymph nodes, which mostly occurs in children and young adults typically presenting withExpand
  • 7
  • Open Access
Azacitidine in the Treatment of Elderly Patients with Acute Myelogenous Leukemia
Abstract 4164 BACKGROUND Effective treatment of the elderly patient with acute myelogenous leukemia (AML) remains a challenging task. Elderly patients with AML usually respond poorly to standardExpand
  • 1
Viability and Potency of Hematopoietic Progenitor Cells after Prolonged Cryopreservation at –80°C
Peripheral blood HPC were collected from 28 donors at our institution between April 1994 and June 2002 using the Baxter CS-3000 blood cell separator. Patient characteristics are shown in table 1 .Expand
  • 4
Molecular profiling of primary central nervous system lymphoma as compared to activated B-cell subtype of diffuse large B-cell lymphoma.
7549Background: The cell of origin of primary central nervous system lymphoma (PCNSL) remains controversial. Data using immunohistochemistry (IHC) and Hans algorithm suggested that both germinal-ce...
  • 1